Where do they fall here? Looks ready to break out this year but some concerns.$1bl net debt to cashno dividend.Many fda problems in the last few yearsMedicare/medicaid looking to cut back.poor management decisionsIntense product competitionOK, those are the negatives. The biggest positive is a huge population of aging baby boomers many of whom did not take care of themselves. Lots of money to spend on healthcare.Where to from here? Merger or acquisition? New product breakthrough? Spending disipline?
St. Jude pays a dividend of $.21/share/quarter. Before bashing, you should get all of your facts straight. It is clear that you know little about St. Jude if you do not know the most basic fact that they pay a dividend.
bump, bump, bump.
Blend stock. Takeout would be north of $70 a share.
If STJ wanted to sell itself - there would be a number of companies that would pay. Big enough to matter but kind of no man's land - think $50 is fair trading value - closer to $60 in take-out.
Problems you listed could apply to many of these companies(medical device).